Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Sun Pharma and partners establish malaria elimination demonstration project

April 27, 2016

hVIVO and SEEK in joint venture investment to develop vaccines against influenza and flu

April 27, 2016

AnGes and VIDO-InterVac collaborate to develop Ebola polyclonal antibody therapy

April 27, 2016

First-in-human results show potential of Ad26.ZEBOV and MVA-BN Filo Ebola vaccines

April 27, 2016

FDA approves AbbVie's sNDA for Viekira Pak

April 26, 2016

Cocrystal Pharma begins phase Ia/Ib study of HCV drug candidate

April 26, 2016

BARDA supports continued development of NewLink's Ebola vaccine candidate

April 26, 2016

SIGA enrolls patients in final cohort of phase III trial of tecovirimat

April 26, 2016

hVIVO reports favorable initial data from phase IIa study of PrEP-001 in influenza

April 25, 2016

GlaxoSmithKline and New York University describe antiprotozoal agents

April 25, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...